Illumina had seven patents in digitalization during Q2 2024. Illumina Inc filed a patent for a reference-based method for compressing genome sequence data, categorizing sequences as perfectly mapped, imperfectly mapped, or unmapped to a reference sequence. Another patent involves a biosensor with a detection device and flow cell, using signal data from light detectors to determine characteristics of analytes of interest while accounting for crosstalk functions. GlobalData’s report on Illumina gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
Illumina had no grants in digitalization as a theme in Q2 2024.
Recent Patents
Application: Method for the compression of genome sequence data (Patent ID: US20240194296A1)
The patent filed by Illumina Inc. describes a method for compressing genomic sequence data obtained from sequencing machines. The method involves determining whether a sequence read is perfectly mapped, imperfectly mapped, or unmapped to a reference sequence, and then encoding the sequences based on this determination. For imperfectly mapped sequences, the number of mismatches is compared to a threshold value, and if it meets the threshold, the mismatches are encoded along with an offset from a previous mismatch into a 1-byte record. The encoding process involves representing alternate nucleotides or bases and the offset within the byte.
Additionally, the method includes encoding perfectly mapped reads using reduced information entropy encoding. The system for implementing this method includes computers and storage devices storing instructions to perform the operations, as well as hardware processors like field programmable gate arrays (FPGAs). The patent also covers a computer-readable storage device with instructions for compressing genomic sequence data, including determining mismatches, encoding imperfectly mapped reads with mismatches and offsets, and using reduced information entropy encoding for perfectly mapped reads. This method aims to efficiently compress genome sequence data for storage and analysis purposes.
To know more about GlobalData’s detailed insights on Illumina, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
